Literature DB >> 2138487

Pharmacokinetics of propofol in women undergoing elective caesarean section.

T Gin1, M A Gregory, K Chan, T Buckley, T E Oh.   

Abstract

We have compared the pharmacokinetics of a bolus induction dose of propofol 2 mg kg-1 in 10 Chinese women undergoing elective Caesarean section with those in six non-pregnant Chinese women having laparoscopic sterilization. Blood propofol concentrations were measured using high pressure liquid chromatography with fluorimetric detection. Pharmacokinetic data were analysed by a model independent method based on statistical moment theory. Data from the laparoscopy group also underwent compartmental analysis, which produced similar kinetic results. Non-compartmental analysis estimated that the women undergoing Caesarean section had a similar elimination half-life (mean 81.27 (SD 18.87) min) and apparent volume of distribution at steady state (2.66 (0.63) litre kg-1) as non-obstetric patients (99.45 (29.40) min and 3.36 (1.87) litre kg-1). Clearance was more rapid in the Caesarean section group (39.32 (8.07) ml min-1 kg-1 vs 29.40 (8.72) ml min-1 kg-1) (P less than 0.05). The increased total body clearance may result from blood loss and delivery of the fetus and placenta at operation, although an increase in extrahepatic clearance is also possible.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2138487     DOI: 10.1093/bja/64.2.148

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  10 in total

Review 1.  Pharmacokinetic optimisation of general anaesthesia in pregnancy.

Authors:  T Gin
Journal:  Clin Pharmacokinet       Date:  1993-07       Impact factor: 6.447

2.  Pharmacokinetics, induction of anaesthesia and safety characteristics of propofol 6% SAZN vs propofol 1% SAZN and Diprivan-10 after bolus injection.

Authors:  C A Knibbe; H J Voortman; L P Aarts; P F Kuks; R Lange; H J Langemeijer; M Danhof
Journal:  Br J Clin Pharmacol       Date:  1999-06       Impact factor: 4.335

Review 3.  Propofol. An update of its use in anaesthesia and conscious sedation.

Authors:  H M Bryson; B R Fulton; D Faulds
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

4.  Disposition of propofol infusions for caesarean section.

Authors:  T Gin; G Yau; K Chan; M A Gregory; T E Oh
Journal:  Can J Anaesth       Date:  1991-01       Impact factor: 5.063

Review 5.  Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review.

Authors:  Gali Pariente; Tom Leibson; Alexandra Carls; Thomasin Adams-Webber; Shinya Ito; Gideon Koren
Journal:  PLoS Med       Date:  2016-11-01       Impact factor: 11.069

6.  Propofol Pharmacokinetics and Estimation of Fetal Propofol Exposure during Mid-Gestational Fetal Surgery: A Maternal-Fetal Sheep Model.

Authors:  Pornswan Ngamprasertwong; Min Dong; Jing Niu; Raja Venkatasubramanian; Alexander A Vinks; Senthilkumar Sadhasivam
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

Review 7.  Pharmacokinetic data in pregnancy: A review of available literature data and important considerations in collecting clinical data.

Authors:  Paola Coppola; Essam Kerwash; Janet Nooney; Amro Omran; Susan Cole
Journal:  Front Med (Lausanne)       Date:  2022-10-04

8.  Paracetamol pharmacokinetics and metabolism in young women.

Authors:  Karel Allegaert; Mariska Y Peeters; Bjorn Beleyn; Anne Smits; Aida Kulo; Kristel van Calsteren; Jan Deprest; Jan de Hoon; Catherijne A J Knibbe
Journal:  BMC Anesthesiol       Date:  2015-11-13       Impact factor: 2.217

9.  Propofol exposure during late stages of pregnancy impairs learning and memory in rat offspring via the BDNF-TrkB signalling pathway.

Authors:  Liang Zhong; Foquan Luo; Weilu Zhao; Yunlin Feng; Liuqin Wu; Jiamei Lin; Tianyin Liu; Shengqiang Wang; Xuexue You; Wei Zhang
Journal:  J Cell Mol Med       Date:  2016-06-14       Impact factor: 5.310

10.  Sudden seizure during cesarean section: A case report.

Authors:  Wenqin Zhou; Qing Zhu
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.